In Germany, flavors and fragrances giant Symrise has invested in Bonumose, a startup developing enzymatic solutions for sweeteners. The minority investment will advance Bonumose’s production of rare monosaccharides, such as tagatose and allulose, that can offer an alternative to artificial sweetener sucrose.
The area represents “a high-priority focus” for Symrise’s North America region within the Taste, Nutrition & Health segment. “This exciting investment forges a strategic partnership. It will enhance our flavor and taste balancing technologies with Bonumose’s innovative and economical tagatose and other alternative sweetening solutions. Combining our technologies, will enable us to offer our customers new pathways to sugar reduction and taste balancing solutions,” Nick Russell, Senior Vice President – Business Incubation Group, Symrise AG, said in a press release.